{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:43:15Z","timestamp":1788424995034,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Micron"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.micron.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T18:32:09Z","timestamp":1413225129000},"page":"107-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Unwrapping microcomputed tomographic images for measuring cortical osteolytic lesions in the 5T2 murine model of myeloma treated by bisphosphonate"],"prefix":"10.1016","volume":"68","author":[{"given":"Mambaye","family":"N\u2019Diaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Libouban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Bouvard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Audran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5886-9513","authenticated-orcid":false,"given":"Daniel","family":"Chappard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micron.2014.10.001_bib0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM199602223340810","article-title":"Management of myeloma with bisphosphonates","volume":"334","author":"Bataille","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micron.2014.10.001_bib0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI115305","article-title":"Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma","volume":"88","author":"Bataille","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.micron.2014.10.001_bib0015","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.1989.7.12.1909","article-title":"Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease","volume":"7","author":"Bataille","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.micron.2014.10.001_bib0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1148\/radiol.2522081756","article-title":"Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging","volume":"252","author":"Bauerle","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.micron.2014.10.001_bib0025","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1200\/JCO.1991.9.8.1397","article-title":"Effect of daily etidronate on the osteolysis of multiple myeloma","volume":"9","author":"Belch","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.micron.2014.10.001_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.micron.2013.08.010","article-title":"Plasma cells release membrane microparticles in a mouse model of multiple myeloma","volume":"54\u201355","author":"Benameur","year":"2013","journal-title":"Micron"},{"key":"10.1016\/j.micron.2014.10.001_bib0035","first-page":"195","article-title":"The efficacy of pamidronate disodium in the treatment of osteolytic lesions and bone pain in multiple myeloma","volume":"9","author":"Berenson","year":"1998","journal-title":"Rev. Contemp. Pharmacother."},{"key":"10.1016\/j.micron.2014.10.001_bib0040","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0","article-title":"Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases","volume":"91","author":"Berenson","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.micron.2014.10.001_bib0045","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/cncr.11139","article-title":"Effectiveness and cost of bisphosphonate therapy in tumor bone disease","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.micron.2014.10.001_bib0050","series-title":"Bone Cancer: Progression and Therapeutic Approaches","first-page":"203","article-title":"Technical aspects: how do we best prepare bone samples for proper histological analysis?","author":"Chappard","year":"2009"},{"key":"10.1016\/j.micron.2014.10.001_bib0055","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jbmr.5650060704","article-title":"Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts","volume":"6","author":"Chappard","year":"1991","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.micron.2014.10.001_bib0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/bjc.1987.241","article-title":"The 5T2 mouse multiple myeloma model: characterization of 5T2 cells within the bone marrow","volume":"56","author":"Croese","year":"1987","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.micron.2014.10.001_bib0065","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1359\/jbmr.2003.18.3.482","article-title":"Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival","volume":"18","author":"Croucher","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.micron.2014.10.001_bib0070","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.V93.5.1697","article-title":"Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease","volume":"93","author":"Dallas","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.micron.2014.10.001_bib0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.micron.2014.10.001_bib0080","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2009.89","article-title":"International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma","volume":"23","author":"Dimopoulos","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.micron.2014.10.001_bib0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00277-008-0621-6","article-title":"Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy","volume":"88","author":"Dinter","year":"2009","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.micron.2014.10.001_bib0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.micron.2014.10.001_bib0095","series-title":"International Conference on Multimedia Computing and Systems (ICMCS)","first-page":"1","article-title":"An omnidirectional image unwrapping approach","author":"El Kadmiri","year":"2011"},{"key":"10.1016\/j.micron.2014.10.001_bib0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jbmr.5650090521","article-title":"Preclinical pharmacology of CGP 42\u2032446, a new, potent, heterocyclic bisphosphonate compound","volume":"9","author":"Green","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.micron.2014.10.001_bib0105","doi-asserted-by":"crossref","first-page":"583439","DOI":"10.1155\/2011\/583439","article-title":"Multiple myeloma: a review of imaging features and radiological techniques","volume":"2011","author":"Healy","year":"2011","journal-title":"Bone Marrow Res."},{"key":"10.1016\/j.micron.2014.10.001_bib0110","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/1097-0142(20000615)88:12+<3022::AID-CNCR19>3.0.CO;2-R","article-title":"Bisphosphonates in multiple myeloma","volume":"88","author":"Kanis","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.micron.2014.10.001_bib0115","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","article-title":"The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs","volume":"103","author":"Kavanagh","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micron.2014.10.001_bib0120","series-title":"Fast Omnidirectional Image Unwrapping on GPU, Euromicro International Conference on Parallel, Distributed and Network-Based Computing (WIP)","author":"Kepucka","year":"2012"},{"key":"10.1016\/j.micron.2014.10.001_bib0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.25051","article-title":"Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model","volume":"127","author":"Labrinidis","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.micron.2014.10.001_bib0130","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1182\/blood-2002-08-2383","article-title":"Macrophage inflammatory protein 1-alpha (MIP-1 alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells","volume":"101","author":"Lentzsch","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.micron.2014.10.001_bib0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S8756-3282(03)00196-0","article-title":"Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model","volume":"33","author":"Libouban","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.micron.2014.10.001_bib0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbrc.2004.02.131","article-title":"Selection of a highly aggressive myeloma cell line by an altered bone microenvironment in the C57BL\/KaLwRij mouse","volume":"316","author":"Libouban","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micron.2014.10.001_bib0145","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.clinthera.2009.05.009","article-title":"Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials","volume":"31","author":"Machado","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.micron.2014.10.001_bib0150","first-page":"582","article-title":"Clinical trials of bisphosphonates in multiple myeloma","volume":"10","author":"Mahindra","year":"2012","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.micron.2014.10.001_bib0155","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1359\/jbmr.070704","article-title":"Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone","volume":"22","author":"Merlotti","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.micron.2014.10.001_bib0160","first-page":"CD003188","article-title":"Bisphosphonates in multiple myeloma: a network meta-analysis","volume":"5","author":"Mhaskar","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.micron.2014.10.001_bib0165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.micron.2014.10.001_bib0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jemt.20814","article-title":"A single pretreatment by zoledronic acid converts metastases from osteolytic to osteoblastic in the rat","volume":"73","author":"Nyangoga","year":"2010","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.micron.2014.10.001_bib0175","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1097-0185(199712)249:4<458::AID-AR5>3.0.CO;2-N","article-title":"Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before during, and after treatment","volume":"249","author":"Pataki","year":"1997","journal-title":"Anat. Rec."},{"key":"10.1016\/j.micron.2014.10.001_bib0180","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCE\/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression","volume":"98","author":"Pearse","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micron.2014.10.001_bib0185","series-title":"Omni-Directional Image Processing for Human Detection and Tracking","author":"Pot\u00fa\u010dek","year":"2006"},{"key":"10.1016\/j.micron.2014.10.001_bib0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbo.2012.02.001","article-title":"Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases","volume":"1","author":"Quattrocchi","year":"2012","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.micron.2014.10.001_bib0195","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/1097-0142(19850301)55:5<1030::AID-CNCR2820550518>3.0.CO;2-Y","article-title":"Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma","volume":"55","author":"Radl","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.micron.2014.10.001_bib0200","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"23","author":"Roodman","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.micron.2014.10.001_bib0205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02555748","article-title":"Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat","volume":"38","author":"Schenk","year":"1986","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.micron.2014.10.001_bib0210","first-page":"453","article-title":"Op\u00e9rations morphologiques floues \u00e0 noyaux variables pour images omnidirectionnelles \u00e0 point de vue unique","volume":"22","author":"Strauss","year":"2005","journal-title":"Traitement du Signal"},{"key":"10.1016\/j.micron.2014.10.001_bib0215","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1040-8428(11)70004-X","article-title":"Established role of bisphosphonate therapy for prevention of skeletal complications from myeloma bone disease","volume":"77","author":"Terpos","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.micron.2014.10.001_bib0220","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micron.2014.10.001_bib0225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00223-012-9570-0","article-title":"Bisphosphonate binding affinity affects drug distribution in both intracortical and trabecular bone of rabbits","volume":"90","author":"Turek","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.micron.2014.10.001_bib0230","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-065X.2003.00035.x","article-title":"Multiple myeloma biology: lessons from the 5TMM models","volume":"194","author":"Vanderkerken","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micron.2014.10.001_bib0235","first-page":"191","article-title":"The 5T2MM murine model of multiple myeloma: maintenance and analysis","volume":"113","author":"Vanderkerken","year":"2005","journal-title":"Methods Mol. Med."}],"container-title":["Micron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968432814001838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968432814001838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T03:51:39Z","timestamp":1746417099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968432814001838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":47,"alternative-id":["S0968432814001838"],"URL":"https:\/\/doi.org\/10.1016\/j.micron.2014.10.001","relation":{},"ISSN":["0968-4328"],"issn-type":[{"value":"0968-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unwrapping microcomputed tomographic images for measuring cortical osteolytic lesions in the 5T2 murine model of myeloma treated by bisphosphonate","name":"articletitle","label":"Article Title"},{"value":"Micron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micron.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}